Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials.
Yucong Zhang, Penghui Yuan, Delin Ma...
https://pubmed.ncbi.nlm.nih.gov/30816336/Actively Recruiting
Led by Fundacio Puigvert · Updated on 2026-04-29
130
Participants Needed
6
Research Sites
N/A
Total Duration
This research investigates surgical treatments for benign prostatic hyperplasia BPH, focusing on comparing two methods MOSES augmented Holmium Laser Enucleation of the Prostate MoLEP and Bipolar Transurethral Resection of the Prostate Bi-TURP. Both are used to relieve urinary symptoms caused by enlarged prostate, with Bi-TURP often considered the standard. Recent technology upgrades like MOSES 2.0 laser fiber and new morcellators may improve MoLEP outcomes, prompting this study to re-evaluate differences between these two approaches. Participants will be randomly assigned to receive either MoLEP or Bi-TURP surgery performed by experienced surgeons. Both procedures follow standard clinical practice and aim to compare hospital stay length, surgical time, bladder catheter duration, postoperative complications, and functional results. The study will take place across multiple centers and includes follow-up phases extending up to five years. During the study, patients will undergo surgery and regular assessments including urinary symptom evaluations and monitoring for complications over the follow-up periods. Key outcomes measured include hospital stay length from surgery to discharge, total surgical time, and bladder catheterization duration. Data will be collected and analyzed at intervals of six months, two years, and five years to observe both short- and long-term effects and treatment outcomes.
CONDITIONS
Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the Prostate
I
Ivan Schwartzmann Jochamowitz, MD
S
Silvia Mateu, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fundacio Puigvert
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery conducted between November 2024 and April 2025
Participants undergo surgical treatment for benign prostatic hyperplasia (BPH) using either Moses assisted Holmium Laser Enucleation of the Prostate (MoLEP) or Bipolar Transurethral Resection of the Prostate (BiTURP).
1 surgical procedure visit (in-person)
Duration - Up to 1 month post-surgery
Participants receive immediate post-operative care including bladder catheterization and monitoring of hospital stay duration following surgery.
Approximately 6 post-operative visits
Duration - Up to 5 years
Participants are followed up to assess surgical outcomes, complications, urinary symptoms, and functional results over short and long term periods.
Follow-up visits at 6 months, 2 years, and 5 years
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Yucong Zhang, Penghui Yuan, Delin Ma...
https://pubmed.ncbi.nlm.nih.gov/30816336/Vineet Gauhar, Peter Gilling, Giacomo Maria Pirola...
https://pubmed.ncbi.nlm.nih.gov/35105516/Rainer M Kuntz, Karin Lehrich, Sascha A Ahyai
https://pubmed.ncbi.nlm.nih.gov/17869409/Richard Naspro, Nazareno Suardi, Andrea Salonia...
https://pubmed.ncbi.nlm.nih.gov/16713070/P J Freyer
https://pubmed.ncbi.nlm.nih.gov/20758920/Stavros Gravas, Mauro Gacci, Christian Gratzke...
https://pubmed.ncbi.nlm.nih.gov/37202311/Thomas E Stout, Michael Borofsky, Ayman Soubra
https://pubmed.ncbi.nlm.nih.gov/33285214/Katherine Dowd, Hazem ElMansy, Walid Sharour...
https://pubmed.ncbi.nlm.nih.gov/34128395/Kenneth F Schulz, Douglas G Altman, David Moher...
https://pubmed.ncbi.nlm.nih.gov/20335313/Fundacio Puigvert
Lead Sponsor